Polypeptide Structure Prediction Using Dynamic Epitope Mapping
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for predicting polypeptide structures, such as X-ray crystallography, are inadequate for poorly expressed or poorly folded proteins, limiting the therapeutic potential of these proteins.
Innovation Solution
A method involving molecular dynamics simulations to generate polypeptide structure data, encoding it into vector maps, and applying machine learning algorithms to predict polypeptide structures, incorporating residue-specific and pairwise properties, and using evolutionary couplings to identify epitopes for therapeutic design.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If X-ray crystallography is used to elucidate polypeptide structure, then structural information can be obtained, but the method fails for poorly expressed or poorly folded proteins
Solution Approach 1:
The patent replaces physical experimental methods (X-ray crystallography) with computational methods (molecular dynamics simulations and machine learning algorithms). This substitution allows structure prediction for proteins that cannot be crystallized or are poorly expressed, overcoming the limitations of traditional experimental approaches while maintaining structural accuracy.
Solution Approach 2:
The patent introduces molecular dynamics simulations as an intermediary step between the polypeptide sequence and the final structure prediction. The simulations generate conformational ensembles that serve as input for machine learning algorithms, enabling the system to handle poorly folded proteins by capturing their dynamic behavior before prediction.
2Loss of information
If molecular dynamics simulations are performed to generate conformational data, then dynamic structural information is obtained, but computational resources and time are significantly increased
Solution Approach 1:
The patent performs molecular dynamics simulations in advance to generate conformational ensembles and extract relevant features (pairwise distances, contact maps, dynamic properties). These pre-computed features are then used as input for machine learning prediction, avoiding the need for extensive simulations during the actual structure prediction phase.
Solution Approach 2:
The patent extracts essential dynamic features from molecular dynamics simulations (such as pairwise distances, contact frequencies, and conformational ensembles) and uses only these extracted features for structure prediction. This extraction approach retains the valuable dynamic information while discarding redundant computational data, reducing resource requirements.
3Ease of manufacture
If static structural techniques are used, then the methodology is simple and well-established, but dynamic polypeptide surfaces and epitopes cannot be accurately mapped
Solution Approach 1:
The patent transitions from static structural analysis to dynamic structural analysis by incorporating molecular dynamics simulations that capture protein flexibility, conformational changes, and dynamic surfaces. This allows accurate mapping of epitopes and binding sites that may only be accessible in specific dynamic states, improving therapeutic design.
Solution Approach 2:
The patent combines multiple computational approaches (molecular dynamics simulations, machine learning algorithms, and evolutionary coupling analysis) into an integrated prediction system. This composite methodology leverages the strengths of each component to achieve accurate dynamic surface mapping while maintaining computational feasibility.
Data Source
AI summary
Disclosed herein are methods of in silico generation of polypeptide structures using time-based data generated from molecular dynamics simulations. Also disclosed herein are methods of predicting an epitope or binding surface of a polypeptide using in silico methods. Also disclosed herein are compositions containing polypeptide therapeutics designed to bind to a predicted epitope structure of a polypeptide, as well as methods of treating a subject by administering to the subject compositions containing the same.